Showing results (61-70 of 265) with videos related to

Sort By:
Pageof 27
Cancer Chemotherapy and Pharmacology|January 1, 1992
Reduced cardiotoxicity and increased cytotoxicity in a novel anthracycline analogue, 4'-amino-3'-hydroxy-doxorubicinR Danesi, N Bernardini, C Agen, et al.
Drugs Under Experimental and Clinical Research|January 1, 1986
The pharmacokinetic profile of clofoctol in rat plasma and tissues after oral and rectal administrationM G Alessandrì, M Ducci, V Scalori, et al.
Journal of Ocular Pharmacology|January 1, 1994
Effect of low molecular weight heparan sulphate on angiogenesis in the rat cornea after chemical cauterizationA Lepri, U Benelli, N Bernardini, et al.
Cancer Research|January 1, 1994
MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesenteryM Costa, R Danesi, C Agen, et al.
Oncology|January 1, 1992
Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell linesR V La Rocca, J G Park, R Danesi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1996
Azidothymidine in combination with 5-fluorouracil in human colorectal cell lines: in vitro synergistic cytotoxicity and DNA-induced strand-breaksM Andreuccetti, G Allegrini, A Antonuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Intravenous azidothymidine with fluorouracil and leucovorin: a phase I-II study in previously untreated metastatic colorectal cancer patientsA Falcone, R Danesi, F Dargenio, et al.
European Journal of Clinical Pharmacology|February 27, 2003
Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case reportG Bocci, R Danesi, G Allegrini, et al.
Toxicology|November 15, 1992
Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heartC Agen, A M Sironi, R Danesi, et al.
British Journal of Cancer|June 1, 2001
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cellsA Di Paolo, R Danesi, S Caputo, et al.
Pageof 27